Solving today’s commercialization challenges by leveraging over three decades of experience to deliver tomorrow’s biopharmaceuticals.
1996 - 1998
St. Paul location opened.
WuXi Pharmatech is formed in China by Dr. Ge Li.
St. Paul, Atlanta, and Philadelphia sites become AppTec Laboratory Services, Inc.
WuXi PharmaTech buys AppTec, and forms WuXi AppTec.
PHL operations continue to manufacture cell banks and provide testing services for biopharmaceuticals.
Philadelphia begins offering integrated advanced therapies testing and manufacturing services.
2015 - 2016
Launched WuXi Hyper-PRO, Viral Vector Production Platform for rapid entry into first in human clinical trials.
Selected as the GMP manufacturing partner for advanced therapies through the California Institute for Regenerative Medicine (CIRM) funded IQVIA Stem Cell Center.
WuXi AppTec spins out advanced therapies manufacturing and testing operations in the US into a separate Business Unit; WuXi Advanced Therapies.
Nohla Therapeutics, a Seattle-based clinical stage cell therapy company entered into a commercial agreement with WuXi Advanced Therapies for the production of its hematopoietic stem and progenitor cell product.
Professionals from multiple disciplines working together to deliver tomorrow’s therapies.
- Molecular Biology
- Quality Assurance/QC Analytical
- Cell Biology
- Analytical/Process Development
- Cell Banking
- Analytical Chemistry
- Technical/Regulatory Services
- Project Management
Interested in joining our team?
Click here to view our open positions.
Browse CDMO and Testing Services
Not sure what service is right for you?
Our experts can help.